Hospices civils de lyon, Hôpital de la Croix-Rousse - Réanimation, Surveillance Continue Médicales et Assistance Respiratoire
Lyon, 69004, France
NCT Number: NCT02832609
The purpose of this study is to study the role of closing volume as a determinant of orthopnea in stable obese subjects. The investigators hypothesized that: (1) increase in closing volume in supine position would be greater in orthopneic than in non-orthopneic subjects, and (2) the relationship of change in closing volume to change in dyspnea with position would be dependent on expiratory flow limitation in the sitting position.
In stable obese subjects, in sitting and supine positions, the investigators measured Borg dyspnea score, static lung volumes, expiratory flow limitation, and single-breath nitrogen expiration test, from which the investigators determined closing volume and closing capacity, slope of phase III, and opening capacity.
Orthopnea was defined as any increase in the Borg score in the supine position from its value in the sitting position
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Lyon, 69004, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
measurements after 30 minutes in complete supine position
Time frame: 30 minutes after changing position (hour 2)
Time frame: 30 minutes after changing position (hour 2)
static lung volumes are composed of vital capacity, FEV1, inspiratory capacity, and reserve expiratory volume and are measured by plethysmography
Time frame: 30 minutes after changing position (hour 2)
NEP test
Hospices Civils de Lyon
Other
Acronym: OBAIRWAY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06474858
Body Weight, COPD
Arnhem, Netherlands
View Trial DetailsNCT03621098
Behavior, Body Weight
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03623204
Body Weight, Dyspnea
Reims, France
View Trial DetailsNCT03035149
Body Weight, Dyspnea
Ottawa, Ontario, Canada
View Trial Details